Skip to content
Genetic Lung Disease

Alpha-1 Antitrypsin Deficiency (AATD)

Genetic Condition Leading to Early Lung Damage and Emphysema

Alpha-1 Antitrypsin Deficiency is an inherited disorder where the body lacks a protective protein (AAT) that shields the lungs from damage. This leads to early-onset emphysema and progressive lung disease, even in non-smokers.

Affects Lungs (and liver)
Cause Genetic deficiency
Progression Early onset, progressive
Treatment Replacement therapy, transplant
Early Breathlessness Without Typical Risk Factors?

Consider genetic causes of lung disease

+91
Confidential | Reviewed by lung specialists
How AATD Affects the Body
Genetic Defect
Inherited mutation
AAT Protein Deficiency
Lack of protection
Lung Damage
Emphysema develops
Respiratory Failure
Transplant required
Important: Genetic & Underdiagnosed

Often misdiagnosed as COPD • Family screening recommended • Early diagnosis improves outcomes

Understanding

What is Alpha-1 Antitrypsin Deficiency?

Alpha-1 Antitrypsin (AAT) is a protein that protects lung tissue from damage.

In AAT deficiency:

  • Low levels of protective protein
  • Lung tissue becomes vulnerable
  • Progressive destruction of air sacs (emphysema)

It may also affect:

  • Liver (due to protein accumulation)
Warning Signs

Early Signs & Symptoms

Young patient with COPD-like symptoms → Evaluate for AATD

Early Stage
Breathlessness on exertion, reduced stamina
Progressive Stage
Chronic cough, wheezing, frequent lung infections
Advanced Stage
Severe breathlessness, oxygen dependency, fatigue
Risk Factors

Causes & Risk Factors

Primary Cause

Genetic mutation (inherited from parents)

Risk Factors
  • Family history
  • Smoking (accelerates damage)
  • Environmental pollutants
Progression

Disease Progression

Early Stage Mild lung damage
Moderate Stage Emphysema develops
Severe Stage Airflow limitation
End Stage Respiratory failure

Early Stage

Mild lung damage

Best time for intervention

Best Time to Act

Moderate Stage

Emphysema develops

Medical Intervention

Severe Stage

Significant airflow limitation

Transplant Evaluation

End Stage Lung Disease

Respiratory failure

Lung transplant required

Transplant Needed
Testing

Diagnosis & Tests

Serum AAT level
Genetic testing
Spirometry
HRCT chest

Check Your Lung Function

Identify early-onset lung disease risk

Management

Treatment Options (Before Transplant)

1. Augmentation Therapy
  • AAT protein replacement
2. Medications
  • Bronchodilators
  • Steroids
3. Lifestyle Changes
  • Strict smoking avoidance
  • Pollution control
4. Pulmonary Rehab
  • Breathing exercises

When is Lung Transplant Needed?

Advanced emphysema

Severe breathlessness

Oxygen dependency

Early Diagnosis Can Slow Disease Progression

Genetic testing is key in suspected cases

Important: Genetic & Underdiagnosed

Often misdiagnosed as COPD • Family screening recommended • Early diagnosis improves outcomes

Medical Management vs Transplant
Medical Management

Stage: Early/Moderate • Goal: Slow progression • Outcome: Good with early care

Lung Transplant

Stage: Advanced • Goal: Replace lungs • Outcome: Life-saving

Options

Lung Transplant Options

Double Lung Transplant

Preferred in advanced disease

Better outcomes

Get My Treatment Plan

Planning

Cost & Planning

Costs depend on:

Disease severity
Need for long-term therapy
Hospital & city

Download Guide

Lung Transplant Cost & Planning Guide

Free & confidential

Get Expert Help

Find Pulmonologists
Find Specialist
Explore Verified Lung Transplant Hospitals

Patient Resources

Genetic counseling guide
Family screening checklist
Lifestyle modification plan
Pre-transplant workup
These follow structured clinical and legal transplant protocols.

Frequently Asked Questions

No, but manageable.

Young patients with COPD-like symptoms.

In advanced cases.

Genetic lung diseases require early recognition and family screening.

Timely intervention can significantly delay disease progression. Stay informed. Act early.